Market Cap

Cannara Biotech, Inc. Market Capitalization:

C$60.3 Million

CAD as of July 1, 2024

US$43.9 Million

business Cannara Biotech, Inc. Company Profile

Cannara Biotech, Inc. Main Stock Listing

TSXV: LOVE

Market Capitalization History of Cannara Biotech, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $80.13 B
MERCK Kommanditgesellschaft auf Aktien $71.24 B
Takeda Pharmaceutical Company Limited $41.23 B
Haleon plc $37.32 B
Teva Pharmaceutical Industries Limited $18.88 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Cannara Biotech, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 C$72.0 M -8.81%
Jan. 1, 2023 C$79.0 M -26.92%
Jan. 1, 2022 C$108.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Cannara Biotech, Inc. Categories

Canada languages Healthcare languages Drug Manufacturers—Specialty & Generic
Canada Healthcare Canada Drug Manufacturers—Specialty & Generic

Stocks & Indices

Cannara Biotech, Inc. has the following listings and related stock indices.


Stock: TSXV: LOVE

Stock: FSX: 8CB

Stock: OTC: LOVFF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.